home / stock / ngenf / ngenf news

NGENF News and Press, NervGen Pharma Corp From 06/10/19

Stock Information
Company Name: NervGen Pharma Corp
Stock Symbol: NGENF
Market: OTC
Website: nervgen.com
Menu
NGENF NGENF Quote NGENF Short NGENF News NGENF Articles NGENF Message Board
Get NGENF Alerts

News, Short Squeeze, Breakout and More Instantly...
NGENF - NervGen Pharma Announces Upgrade to the OTCQX Best Market in the U.S.

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2019) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today an...
NGENF - OTC Markets Group Welcomes NervGen Pharma to OTCQX

NEW YORK , June 10, 2019 /PRNewswire/ --   OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF) ("NervGen"), a regenerative medicine company dedicated to cr...

NGENF - NervGen Pharma Presenting at the 9th Annual LD Micro Invitational

Vancouver, British Columbia--(Newsfile Corp. - June 4, 2019) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage, including spinal cord and peripheral ner...

NGENF - NervGen Pharma Engages Torrey Hills Capital for Investor Relations

Vancouver, British Columbia--(Newsfile Corp. - June 3, 2019) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage, including spinal cord and peripheral ner...
NGENF - NervGen Pharma Appoints Dr. Denis Bosc as Vice President of Manufacturing

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2019) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage, including spinal cord and peripheral ner...

NGENF - NervGen Pharma Commences Trading on OTCQB

Vancouver, British Columbia--(Newsfile Corp. - May 3, 2019) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF ) ("NervGen" or the "Company"), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage including spinal cord and peripheral ner...

Previous 10 Next 10